Nutra Pharma Corp NPHC Stock Analysis
- OTCCE
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Oct 14
Last close · Previous close $0.00
- Market cap
- At the Oct 14 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- Last 12 months
Price chart
$0.00unchangedWed, Oct 14 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Oct 13
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Valuation
Financials
Dividends
About Nutra Pharma Corp
Nutra Pharma Corp. is a biopharmaceutical company engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. The Company's products are Cobroxin and Nyloxin/Nyloxin Extra Strength. The wholly owned subsidiaries of the Company are ReceptoPharm, Inc. (ReceptoPharm) and Designer Diagnostics, Inc. (Designer Diagnostics).
- Sector
- Industry
- Headquarters
- Exchange
- OTCCE
- Asset type
- Common stock
- Price history since
NPHC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
NPHC stock FAQ
What is NPHC stock’s price today?
Nutra Pharma (NPHC) traded at $0.00 at the close on , unchanged from the previous close of $0.00.
What exchange does NPHC trade on?
Nutra Pharma trades on the OTCCE under the ticker symbol NPHC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.